Aptevo Therapeutics, Inc. (APVO)
6.71
+0.12
(+1.82%)
USD |
NASDAQ |
Feb 13, 16:00
6.92
+0.21
(+3.13%)
After-Hours: 20:00
Aptevo Therapeutics EPS Diluted (Quarterly) : -40.13 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
| Dermata Therapeutics, Inc. | -1.648 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.028M |
| Total Expenses (Quarterly) | 9.028M |
| Enterprise Value | -10.38M |
| Earnings Yield | -49.65K% |
| Normalized Earnings Yield | -49645.17 |